Clinical Trials Logo

Uterine Cancer clinical trials

View clinical trials related to Uterine Cancer.

Filter by:

NCT ID: NCT01962272 Completed - Gastric Cancer Clinical Trials

The Effect of Nutritional Counseling for Cancer Patients

Start date: January 2010
Phase: Phase 4
Study type: Interventional

Background and aims: Cancer-related malnutrition is multifactorial and related to a bad prognosis. The aim of this study was to investigate the effect of intensive, individual dietary counseling of patients in radiotherapy and/or chemotherapy for gynecologic-, gastric-, or esophageal cancer.

NCT ID: NCT01953107 Completed - Ovarian Cancer Clinical Trials

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Start date: November 2013
Phase: Phase 4
Study type: Interventional

The prevalence of anemia in gynecologic oncology new patients has been seen in previous studies to be as high as 35-59%. this population includes women with several types of gynecologic malignancies. Therefore, it is assumed that the origin of the anemia can be due to anemia of chronic disease and iron deficiency anemia. No previous studies have looked at the efficacy of oral iron supplementation with concurrent Vitamin C in women with newly diagnosed gynecologic malignancies. Hypothesis: In newly diagnosed gynecologic oncology patients who are surgical candidates does treatment with 3-6 weeks of oral ferrous fumarate 300 mg once a day improve the mean change in hemoglobin levels, from baseline to pre-operative, in comparison to placebo.

NCT ID: NCT01870947 Completed - Obesity Clinical Trials

Assisted Exercise in Obese Endometrial Cancer Patients

Start date: September 7, 2011
Phase: N/A
Study type: Interventional

This is an assisted exercise trial involving exercise on a stationary bike, brain imaging and DNA(genetics)sampling. The purpose of this study is to find out if performing a progressive, supervised assisted exercise program on a stationary bike improves quality of life, increases motivation to continue to exercise, improves dietary behavior and leads to sustained weight loss in women who have had early-stage endometrial cancer. Questionnaires will be used to assess exercise motivation and dietary behavior. Brain's responses to different visual images will also be assessed.

NCT ID: NCT01709175 Completed - Breast Cancer Clinical Trials

Strength Training Study for Survivors of Breast and Gynecologic Cancer

Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to compare once-a-week vs. twice-a-week strength training in survivors of breast and gynecologic cancer to determine which is the optimal exercise prescription.

NCT ID: NCT01650376 Active, not recruiting - Uterine Cancer Clinical Trials

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Start date: August 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the maximum tolerated dose (MTD) of the investigational agent, olaparib, to give in combination with carboplatin and paclitaxel in patients with relapsed ovarian cancer or uterine cancer. Furthermore, the investigators intend to study the safety and tolerability of the study treatment, response to treatment, time to disease progression, and overall survival.

NCT ID: NCT01601548 Completed - Breast Cancer Clinical Trials

Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy

Start date: July 2012
Phase: N/A
Study type: Interventional

Upon the completion of aggressive chemotherapy and radiation for curative intent cancers, many cancer survivors suffer from a myriad of symptoms ranging from physical symptoms such as hot flashes, insomnia, and fatigue to psychosocial symptoms including depression and anxiety. Mindfulness Based Cancer Recovery (MBCR) is a type of mind-body intervention. Mind-body interventions are defined as practices or interventions that focus on the connection and integration of the mind and body and the ability for these connections to effect changes on physical, emotional and spiritual levels for the purpose of promoting health and well being.

NCT ID: NCT01600040 Active, not recruiting - Cervical Cancer Clinical Trials

Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix

Start date: May 2013
Phase: N/A
Study type: Interventional

Proton beam radiation therapy is known to spare surrounding normal tissues from radiation. Proton beam radiation delivers less radiation beyond the area of the target tissues. This may reduce side effects that patients would normally experience with standard (photon) radiation therapy which tends to unavoidably include more normal tissue along with tumor target tissue. In this research study, the investigators are looking to determine if proton beam radiation is effective in controlling your cancer growth. The investigators are also looking to see if proton beam radiation can reduce side effects when compared to standard radiation treatment (photon radiation).

NCT ID: NCT01570218 Completed - Breast Cancer Clinical Trials

Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy

Start date: February 2010
Phase: N/A
Study type: Interventional

OBJETIVE: To study the influence of musicotherapy in reduction of fatigue related to cancer in patients with breast's or gynecology's cancer, during the radiotherapy treatment.

NCT ID: NCT01492179 Completed - Uterine Cancer Clinical Trials

Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.

PoPuLAR
Start date: November 2011
Phase: Phase 4
Study type: Interventional

Local anesthetics (LA) are increasingly used for postoperative pain management. Speicifically, several studies have found benefit of LA injected intra-abdominally following abdominal hysterectomy. However, it remains unclear whether the pain relief seen is due to local anesthetic mechanisms within the abdominal cavity or through systemic absorption. The aim of this study is to assess whether lidocaine administered intravenously has similar analgesic efficacy as the same dose administered intra-abdominally in patients undergoing abdominal hysterectomy. All patients would have rescue analgesia using the patient controlled analgesia (PCA) pump with morphine in order to achieve adequate pain management during 24 h.

NCT ID: NCT01432015 Completed - Ovarian Cancer Clinical Trials

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Start date: September 2011
Phase: Phase 4
Study type: Interventional

Nausea and vomiting are two of the more concerning adverse outcomes associated with chemotherapy in the treatment of gynecologic malignancies. In fact, nearly 90% of cancer patients develop chemotherapy induced nausea and vomiting (CINV) following treatment with carboplatin and paclitaxel. The successful control of chemotherapy induced nausea and vomiting (CINV) is thus, of paramount importance in ensuring optimal treatment and sustaining a cancer patient's quality of life.